CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,323,510
- in 6 filings, $5.0M under 10b5-1 plans
Net −$7,323,510. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-10 | Vig Pamela Head of Research & Development | Grant or award | +807 | $13.57 | $11K | 21,242 |
| 2022-05-10 | Peetz Christopher President and CEO | Grant or award | +1,500 | $13.57 | $20K | 69,527 |
| 2022-05-10 | Clements Ian Chief Financial Officer | Grant or award | +1,125 | $13.57 | $15K | 29,686 |
| 2022-01-06 | Vig Pamela Chief Scientific Officer | Grant or award | +10,000 | 20,435 | ||
| 2022-01-06 | Vig Pamela Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-01-06 | Radovich Peter Chief Operating Officer | Grant or award | +10,000 | 22,231 | ||
| 2022-01-06 | Radovich Peter Chief Operating Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-01-06 | Peetz Christopher President and CEO | Grant or award | +40,000 | 68,027 | ||
| 2022-01-06 | Peetz Christopher President and CEO | Grant or award · Stock Option (right to buy) | +240,000 | 240,000 | ||
| 2022-01-06 | Longpre Lara Chief Development Officer | Grant or award | +10,000 | 94,998 | ||
| 2022-01-06 | Longpre Lara Chief Development Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-01-06 | Clements Ian Chief Financial Officer | Grant or award | +10,000 | 28,561 | ||
| 2022-01-06 | Clements Ian Chief Financial Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-11-26 | Clements Ian Chief Financial Officer | Purchase | +750 | $13.90 | $10K | 18,561 |
| 2021-11-24 | Clements Ian Chief Financial Officer | Purchase | +700 | $14.40 | $10K | 17,811 |
| 2021-11-24 | Peetz Christopher President and CEO | Purchase | +7,000 | $14.40 | $101K | 28,027 |
| 2021-11-10 | Vig Pamela Chief Scientific Officer | Grant or award | +768 | $13.52 | $10K | 10,435 |
| 2021-11-10 | Tucker Edwin Jonathan Chief Medical Officer | Grant or award | +70 | $13.52 | $946 | 45,838 |
| 2021-11-10 | Radovich Peter Chief Operating Officer | Grant or award | +958 | $13.52 | $13K | 12,231 |
| 2021-11-10 | Longpre Lara Chief Development Officer | Grant or award | +753 | $13.52 | $10K | 84,998 |
Page 27 of 32 · 635 trades